Merck Agrees To Buy Rare Disease Specialist Acceleron Pharma For $11.5 Billon - NewsBreak

Merck & Co. (MRK) - Get Merck & Co., Inc. (MRK) Report agreed to buy Acceleron Pharma Inc. (XLRN) - Get Acceleron Pharma Inc Report Thursday in a deal that values the rare drug specialists at around $11.5 billion. Merck will pay $180 per share for Cambridge, Massachusetts-based Acceleron, a...